HPN328, a Trispecific T Cell-Activating Protein Construct Targeting DLL3-Expressing Solid Tumors.
Molloy ME, Aaron WH, Barath M, Bush MC, Callihan EC, Carlin K, Cremin M, Evans T, Guerrero MG, Hemmati G, Hundal AS, Lao L, Laurie P, Lemon BD, Lin SJ, O'Rear J, Patnaik P, Sotelo Rocha S, Santiago L, Strobel KL, Valenzuela LB, Wu CH, Yu S, Yu TZ, Anand BS, Law CL, Sun LL, Wesche H, Austin RJ.
Molloy ME, et al. Among authors: o rear j.
Mol Cancer Ther. 2024 Sep 4;23(9):1294-1304. doi: 10.1158/1535-7163.MCT-23-0524.
Mol Cancer Ther. 2024.
PMID: 38670552
Free PMC article.